| Jeffrey Matthew Howard, MD, PHD | |
|
100 Brickhill Ave, South Portland, ME 04106-1999 | |
| (207) 773-1728 | |
| Not Available |
| Full Name | Jeffrey Matthew Howard |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 9 Years |
| Location | 100 Brickhill Ave, South Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700270758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD25735 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Houlton Regional Hospital | Houlton, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
| Mainehealth | 7517860588 | 2067 |
News Archive
Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.
One in five people with depression have suicidal thoughts despite treatment with antidepressants. This is shown by a new study from iPSYCH. The results can be used to examine whether more targeted treatment could be provided for patients where medication does not have a sufficient effect.
The National Cancer Institute today announced that a team co-led by Fred Hutchinson Cancer Research Center and The Broad Institute in Cambridge, Mass., has been selected to participate in a National Cancer Institute-funded research consortium dedicated to understanding the molecular basis of cancer.
The structure of an entire HIV genome has been decoded for the first time by researchers at the University of North Carolina at Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.
Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.
› Verified 6 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847 |
News Archive
Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.
One in five people with depression have suicidal thoughts despite treatment with antidepressants. This is shown by a new study from iPSYCH. The results can be used to examine whether more targeted treatment could be provided for patients where medication does not have a sufficient effect.
The National Cancer Institute today announced that a team co-led by Fred Hutchinson Cancer Research Center and The Broad Institute in Cambridge, Mass., has been selected to participate in a National Cancer Institute-funded research consortium dedicated to understanding the molecular basis of cancer.
The structure of an entire HIV genome has been decoded for the first time by researchers at the University of North Carolina at Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.
Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.
One in five people with depression have suicidal thoughts despite treatment with antidepressants. This is shown by a new study from iPSYCH. The results can be used to examine whether more targeted treatment could be provided for patients where medication does not have a sufficient effect.
The National Cancer Institute today announced that a team co-led by Fred Hutchinson Cancer Research Center and The Broad Institute in Cambridge, Mass., has been selected to participate in a National Cancer Institute-funded research consortium dedicated to understanding the molecular basis of cancer.
The structure of an entire HIV genome has been decoded for the first time by researchers at the University of North Carolina at Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.
Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Matthew Howard, MD, PHD 587 Sawyer St, South Portland, ME 04106-4834 Ph: (713) 751-9015 | Jeffrey Matthew Howard, MD, PHD 100 Brickhill Ave, South Portland, ME 04106-1999 Ph: (207) 773-1728 |
News Archive
Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.
One in five people with depression have suicidal thoughts despite treatment with antidepressants. This is shown by a new study from iPSYCH. The results can be used to examine whether more targeted treatment could be provided for patients where medication does not have a sufficient effect.
The National Cancer Institute today announced that a team co-led by Fred Hutchinson Cancer Research Center and The Broad Institute in Cambridge, Mass., has been selected to participate in a National Cancer Institute-funded research consortium dedicated to understanding the molecular basis of cancer.
The structure of an entire HIV genome has been decoded for the first time by researchers at the University of North Carolina at Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.
Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.
› Verified 6 days ago
Stephen Thomas Ryan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-773-1728 Fax: 207-773-8153 | |
Lily C Wang, M.D., PHD Urology Medicare: Medicare Enrolled Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-773-1728 | |
Lisa T Beaule, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-773-1728 Fax: 207-772-4062 | |
Dr. Sanchita Bose, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-773-1728 | |
Brian M Jumper, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Avenue, South Portland, ME 04106 Phone: 207-773-1728 Fax: 207-772-4062 | |
Moritz H Hansen, MD Urology Medicare: Medicare Enrolled Practice Location: 100 Brickhill Avenue, South Portland, ME 04106 Phone: 207-773-1728 Fax: 207-772-4062 | |
Dr. David J Chalmers, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, South Portland, ME 04106 Phone: 207-773-1728 |